PREDICTIVE ONCOLOGY INC's ticker is and the CUSIP is 74039M200. A total of 27 filers reported holding PREDICTIVE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $695,443 | +6.6% | 2,128,039 | 0.0% | 0.00% | – |
| Q4 2022 | $652,457 | -14.7% | 2,128,039 | +0.1% | 0.00% | – |
| Q3 2022 | $765,000 | -12.3% | 2,126,663 | 0.0% | 0.00% | – |
| Q2 2022 | $872,000 | -58.0% | 2,126,663 | 0.0% | 0.00% | – |
| Q1 2022 | $2,078,000 | +2.7% | 2,126,663 | 0.0% | 0.00% | – |
| Q4 2021 | $2,024,000 | -24.0% | 2,126,663 | +6.3% | 0.00% | – |
| Q3 2021 | $2,662,000 | +10.5% | 2,001,229 | +8.9% | 0.00% | – |
| Q2 2021 | $2,408,000 | +259.4% | 1,838,085 | +231.9% | 0.00% | – |
| Q1 2021 | $670,000 | +155.7% | 553,759 | +54.6% | 0.00% | – |
| Q4 2020 | $262,000 | +15.4% | 358,289 | +28.6% | 0.00% | – |
| Q3 2020 | $227,000 | +305.4% | 278,567 | +708.6% | 0.00% | – |
| Q2 2020 | $56,000 | +55.6% | 34,451 | +50.6% | 0.00% | – |
| Q1 2020 | $36,000 | -35.7% | 22,881 | +6.7% | 0.00% | – |
| Q4 2019 | $56,000 | – | 21,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 207,144 | $63,593 | 0.04% |
| RB Capital Management, LLC | 159,500 | $48,903 | 0.02% |
| SAX WEALTH ADVISORS, LLC | 147,437 | $45,204 | 0.01% |
| Virtu Financial LLC | 80,103 | $25 | 0.00% |
| Prosperity Consulting Group, LLC | 14,097 | $4,322 | 0.00% |
| Fusion Capital, LLC | 11,750 | $3,603 | 0.00% |
| Csenge Advisory Group | 30,000 | $9,198 | 0.00% |
| PSI Advisors, LLC | 7,963 | $2,441 | 0.00% |
| Private Advisor Group, LLC | 29,805 | $9 | 0.00% |
| JANE STREET GROUP, LLC | 21,204 | $6,501 | 0.00% |